Development Level

Tclin 3 | 613
Tchem 2 | 1,598
Tbio 1 | 11,445

Collection

GPCR: IDG Consortium (Targets) 1 | 126
RFA-RM-18-021 1 | 328

IMPC Phenotype

abnormal behavioral response t... 1 | 66
decreased anxiety-related resp... 1 | 12
decreased total body fat amoun... 1 | 207
increased lean body mass 1 | 172
preweaning lethality, complete... 1 | 979
preweaning lethality, incomple... 1 | 499

Disease

Carcinoma 5 | 11,493
Schizophrenia 5 | 1,160
medulloblastoma, large-cell 5 | 6,241
Alcoholic Intoxication, Chronic 4 | 289
Depressive disorder 3 | 409
Epilepsy 3 | 792
Mental Depression 3 | 333
astrocytic glioma 3 | 2,597
atypical teratoid / rhabdoid tumor 3 | 5,112
ependymoma 3 | 4,679
osteosarcoma 3 | 7,950
primitive neuroectodermal tumor 3 | 3,035
psoriasis 3 | 6,694
Alcohol abuse 2 | 50
Attention deficit hyperactivity disorder 2 | 278
Bipolar Disorder 2 | 666
Cerebellar Ataxia 2 | 304
Cluster headache syndrome 2 | 8
Developmental regression 2 | 95
Epileptic encephalopathy 2 | 26
Hypotension 2 | 82
Loss of developmental milestones 2 | 95
Mental deterioration in childhood 2 | 95
Migraine 2 | 83
Neurodevelopmental Disorders 2 | 70
Neurodevelopmental regression 2 | 95
Obesity 2 | 678
Psychomotor regression 2 | 95
Psychomotor regression beginning in infancy 2 | 95
Psychomotor regression in infants 2 | 95
Psychomotor regression, progressive 2 | 95
Psychotic Disorders 2 | 151
Seizures 2 | 596
Status Epilepticus 2 | 98
Substance Withdrawal Syndrome 2 | 55
adult high grade glioma 2 | 3,801
ductal carcinoma in situ 2 | 1,745
glioblastoma 2 | 5,792
group 3 medulloblastoma 2 | 4,104
invasive ductal carcinoma 2 | 2,951
oligodendroglioma 2 | 2,850
ovarian cancer 2 | 8,520
Abnormal brain FDG positron emission tomography 1 | 9
Absence Epilepsy 1 | 22
Alcohol dependence 1 | 107
Bradycardia 1 | 36
Brain hypomyelination 1 | 11
Bronchitis 1 | 43
Cannabis use 1 | 6
Catalepsy 1 | 15
Cocaine Dependence 1 | 51
Cocaine abuse 1 | 19
Common cold 1 | 67
Drug Hypersensitivity 1 | 34
Drug allergy 1 | 36
Dysmenorrhea 1 | 21
Early infantile epileptic encephalopathy with suppression bursts 1 | 10
Early myoclonic encephalopathy 1 | 15
Epilepsies, Myoclonic 1 | 32
Epileptic drop attack 1 | 11
Febrile Convulsions 1 | 14
Generalized myoclonic seizures 1 | 30
Genetic Predisposition to Disease 1 | 27
Hypertonic seizures 1 | 8
Hypomyelinating leukodystrophy 6 1 | 26
Hypotonic seizures 1 | 11
Hypsarrhythmia 1 | 25
Impaired horizontal smooth pursuit 1 | 6
Infarction, Middle Cerebral Artery 1 | 33
Ischemia 1 | 28
Ischemic Attack, Transient 1 | 10
Leukemia, Myelocytic, Acute 1 | 120
Leukemia, Myeloid, Acute 1 | 105
Marijuana Abuse 1 | 31
Mental deterioration 1 | 32
Myocardial Perfusion Imaging Adjunct 1 | 25
Myoclonic Epilepsies, Progressive 1 | 44
Nasal congestion 1 | 21
Nasal discharge 1 | 24
Neonatal onset 1 | 21
Opiate dependence 1 | 29
Ovarian hyperstimulation syndrome 1 | 19
Pain 1 | 103
Pancreatitis 1 | 123
Parkinson Disease, Secondary 1 | 9
Paroxysmal supraventricular tachycardia 1 | 12
Personality disorder 1 | 25
Photosensitivity of skin 1 | 51
Pulmonary emphysema 1 | 48
Retinal ischemia 1 | 7
Spastic Quadriplegia 1 | 42
Spindle cell hemangioma 1 | 16
Subarachnoid Hemorrhage 1 | 7
Substance abuse 1 | 59
Tension-type headache 1 | 10
Tonic - clonic seizures 1 | 44
Transient Ischemic Attack 1 | 10
Vascular headache 1 | 7
West Syndrome 1 | 28
obsessive-compulsive disorder 1 | 61

Tissue

Blood and immune system 6 | 16,909
Digestive Tract 6 | 17,369
Endocrine System 6 | 18,159
Female tissues 6 | 17,400
Liver and Pancreas 6 | 16,750
Male tissues 6 | 17,142
Nervous System 6 | 16,725
Respiratory system 6 | 16,393
Skin and soft tissues 6 | 17,230
Urinary Tract 6 | 16,678
Cardiovascular System 5 | 15,192

Target Family

GPCR 4 | 408
Non-IDG 1 | 12,091
Transporter 1 | 473

GO Process

negative regulation of synapti... 6 | 6
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cannabinoid receptor 2 CNR2 Tchem GPCR -2.45761 269.7 345
5-hydroxytryptamine receptor 1B HTR1B Tclin GPCR -3.03042 1068.4 211
Adenosine receptor A1 ADORA1 Tclin GPCR -3.08657 1177.9 342
Syntaxin-binding protein 1 STXBP1 Tbio Non-IDG -2.30714 221.0 351
Sodium- and chloride-dependent GABA transporter 1 SLC6A1 Tclin Transporter -2.91010 786.7 172
Neuropeptide Y receptor type 5 NPY5R Tchem GPCR -1.66945 36.9 193